Abstract
IL-22 serves a protective function in the intestinal barrier. These protective properties of IL-22 may offer a potential treatment for ulcerative colitis (UC). However, the exact mechanisms of action remain unclear. Autophagy plays an important protective role in stabilizing the intestinal barrier. We aimed to explore the role of autophagy in the IL-22-mediated-protective effects in UC. Dextran sulfate sodium (DSS) was administrated via drinking water over 7 days to induce acute UC in BALB/c mice. Treatments with IL-22 (0.25 μg/10 g bodyweight) were started by intraperitoneal injection on days 1, 3, and 5. Weight, disease activity index, histological score, and myeloperoxidase (MPO) activity were used to evaluate the severity of colitis. The expressions of occludin and autophagy-related proteins LC3BII/I were measured by western blot analysis. The lipopolysaccharide-induced HT-29 cell model was used to explore the mechanism. In vivo, IL-22 significantly alleviated DSS-induced clinical manifestations, reduced histological injury, and inhibited MPO activity. IL-22 upregulated the expression of occludin and the LC3B II/I ratio in the colon. In vitro, IL-22 significantly lowered TNF-α levels and enhanced the expression of occludin and the LC3B II/I ratio. Importantly, inhibiting autophagy in vitro by 3-Methyladenine (3-MA) attenuated the occludin protective effects of IL-22. In summary, our findings demonstrate that IL-22 ameliorates DSS-induced ulcerative colitis, which may be attributable to activating autophagy and then promoting occludin expression.
Similar content being viewed by others
Data availability
The data used to support the findings of this study are included within the article.
References
Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel J-F (2017) Ulcerative colitis. Lancet 389(10080):1756–1770. https://doi.org/10.1016/s0140-6736(16)32126-2
Ramos GP, Papadakis KA (2019) Mechanisms of disease: inflammatory bowel diseases. Mayo Clin Proc 94(1):155–165. https://doi.org/10.1016/j.mayocp.2018.09.013
Tan Y, Guan Y, Sun Y, Zheng C (2019) Correlation of intestinal mucosal healing and tight junction protein expression in ulcerative colitis patients. Am J Med Sci 357(3):195–204. https://doi.org/10.1016/j.amjms.2018.11.011
Vivinus-Nebot M, Frin-Mathy G, Bzioueche H, Dainese R, Bernard G, Anty R, Filippi J, Saint-Paul MC, Tulic MK, Verhasselt V, Hebuterne X, Piche T (2014) Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Gut 63(5):744–752. https://doi.org/10.1136/gutjnl-2012-304066
Kim S, Hong EH, Lee CK, Ryu Y, Jeong H, Heo S, Lee JJ, Ko HJ (2022) Amelioration of DSS-induced acute colitis in mice by recombinant monomeric human interleukin-22. Immune Netw 22(3):e26. https://doi.org/10.4110/in.2022.22.e26
Lindemans CA, Calafiore M, Mertelsmann AM, O’Connor MH, Dudakov JA, Jenq RR, Velardi E, Young LF, Smith OM, Lawrence G, Ivanov JA, Fu YY, Takashima S, Hua G, Martin ML, O’Rourke KP, Lo YH, Mokry M, Romera-Hernandez M, Cupedo T, Dow L, Nieuwenhuis EE, Shroyer NF, Liu C, Kolesnick R, van den Brink MRM, Hanash AM (2015) Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. Nature 528(7583):560–564. https://doi.org/10.1038/nature16460
Zhang X, Liu S, Wang Y, Hu H, Li L, Wu Y, Cao D, Cai Y, Zhang J, Zhang X (2019) Interleukin22 regulates the homeostasis of the intestinal epithelium during inflammation. Int J Mol Med 43(4):1657–1668. https://doi.org/10.3892/ijmm.2019.4092
Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, Bhan AK, Blumberg RS, Xavier RJ, Mizoguchi A (2008) IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 118(2):534–544. https://doi.org/10.1172/JCI33194
Qiu Y, Jiang Z, Hu S, Wang L, Ma X, Yang X (2017) Lactobacillus plantarum enhanced IL-22 production in natural Killer (NK) cells that protect the integrity of intestinal epithelial cell barrier damaged by enterotoxigenic Escherichia coli. Int J Mol Sci. https://doi.org/10.3390/ijms18112409
Mizushima N (2018) A brief history of autophagy from cell biology to physiology and disease. Nat Cell Biol 20(5):521–527. https://doi.org/10.1038/s41556-018-0092-5
Larabi A, Barnich N, Nguyen HTT (2020) New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD. Autophagy 16(1):38–51. https://doi.org/10.1080/15548627.2019.1635384
Wong M, Ganapathy AS, Suchanec E, Laidler L, Ma T, Nighot P (2019) Intestinal epithelial tight junction barrier regulation by autophagy-related protein ATG6/beclin 1. Am J Physiol Cell Physiol 316(5):C753–C765. https://doi.org/10.1152/ajpcell.00246.2018
Zhang C, Yan J, Xiao Y, Shen Y, Wang J, Ge W, Chen Y (2017) Inhibition of autophagic degradation process contributes to claudin-2 expression increase and epithelial tight junction dysfunction in TNF-alpha treated cell monolayers. Int J Mol Sci. https://doi.org/10.3390/ijms18010157
Shao L, Xiong X, Zhang Y, Miao H, Ren Y, Tang X, Song J, Wang C (2020) IL-22 ameliorates LPS-induced acute liver injury by autophagy activation through ATF4-ATG7 signaling. Cell Death Dis 11(11):970. https://doi.org/10.1038/s41419-020-03176-4
Mo R, Lai R, Lu J, Zhuang Y, Zhou T, Jiang S, Ren P, Li Z, Cao Z, Liu Y, Chen L, Xiong L, Wang P, Wang H, Cai W, Xiang X, Bao S, Xie Q (2018) Enhanced autophagy contributes to protective effects of IL-22 against acetaminophen-induced liver injury. Theranostics 8(15):4170–4180. https://doi.org/10.7150/thno.25798
Ke Y, Sun D, Jiang G, Kaplan HJ, Shao H (2011) IL-22-induced regulatory CD11b+ APCs suppress experimental autoimmune uveitis. J Immunol 187(5):2130–2139. https://doi.org/10.4049/jimmunol.1100482
Wang X, Zeng HC, Huang YR, He QZ (2020) Chlamydia muridarum alleviates colitis via the IL-22/occludin signal pathway. Biomed Res Int 2020:8894331. https://doi.org/10.1155/2020/8894331
Wang Y, Liu J, Huang Z, Li Y, Liang Y, Luo C, Ni C, Xie J, Su Z, Chen J, Li C (2021) Coptisine ameliorates DSS-induced ulcerative colitis via improving intestinal barrier dysfunction and suppressing inflammatory response. Eur J Pharmacol 896:173912. https://doi.org/10.1016/j.ejphar.2021.173912
Neurath MF (2014) Cytokines in inflammatory bowel disease. Nat Rev Immunol 14(5):329–342. https://doi.org/10.1038/nri3661
Kobayashi T, Siegmund B, Le Berre C, Wei SC, Ferrante M, Shen B, Bernstein CN, Danese S, Peyrin-Biroulet L, Hibi T (2020) Ulcerative colitis. Nat Rev Dis Primers 6(1):74. https://doi.org/10.1038/s41572-020-0205-x
Mizoguchi A, Yano A, Himuro H, Ezaki Y, Sadanaga T, Mizoguchi E (2018) Clinical importance of IL-22 cascade in IBD. J Gastroenterol 53(4):465–474. https://doi.org/10.1007/s00535-017-1401-7
Tan Y, Zheng C (2018) Effects of Alpinetin on intestinal barrier function, inflammation and oxidative stress in dextran sulfate sodium-induced ulcerative colitis mice. Am J Med Sci 355(4):377–386. https://doi.org/10.1016/j.amjms.2018.01.002
Mir H, Meena AS, Chaudhry KK, Shukla PK, Gangwar R, Manda B, Padala MK, Shen L, Turner JR, Dietrich P, Dragatsis I, Rao R (2016) Occludin deficiency promotes ethanol-induced disruption of colonic epithelial junctions, gut barrier dysfunction and liver damage in mice. Biochim Biophys Acta 1860(4):765–774. https://doi.org/10.1016/j.bbagen.2015.12.013
Van Itallie CM, Fanning AS, Holmes J, Anderson JM (2010) Occludin is required for cytokine-induced regulation of tight junction barriers. J Cell Sci 123(Pt 16):2844–2852. https://doi.org/10.1242/jcs.065581
Kuo WT, Shen L, Zuo L, Shashikanth N, Ong M, Wu L, Zha J, Edelblum KL, Wang Y, Wang Y, Nilsen SP, Turner JR (2019) Inflammation-induced Occludin downregulation limits epithelial apoptosis by suppressing caspase-3 expression. Gastroenterology 157(5):1323–1337. https://doi.org/10.1053/j.gastro.2019.07.058
Sugimoto S, Naganuma M, Kiyohara H, Arai M, Ono K, Mori K, Saigusa K, Nanki K, Takeshita K, Takeshita T, Mutaguchi M, Mizuno S, Bessho R, Nakazato Y, Hisamatsu T, Inoue N, Ogata H, Iwao Y, Kanai T (2016) Clinical efficacy and safety of Oral Qing-Dai in patients with ulcerative colitis: a single-center open-label prospective study. Digestion 93(3):193–201. https://doi.org/10.1159/000444217
Zha JM, Li HS, Lin Q, Kuo WT, Jiang ZH, Tsai PY, Ding N, Wu J, Xu SF, Wang YT, Pan J, Zhou XM, Chen K, Tao M, Odenwald MA, Tamura A, Tsukita S, Turner JR, He WQ (2019) Interleukin 22 Expands transit-amplifying cells while depleting Lgr5(+) stem cells via inhibition of Wnt and notch signaling. Cell Mol Gastroenterol Hepatol 7(2):255–274. https://doi.org/10.1016/j.jcmgh.2018.09.006
Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ, Ouyang W (2008) Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14(3):282–289. https://doi.org/10.1038/nm1720
Wolk K, Witte E, Wallace E, Docke WD, Kunz S, Asadullah K, Volk HD, Sterry W, Sabat R (2006) IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 36(5):1309–1323. https://doi.org/10.1002/eji.200535503
Xu XQ, Liu Y, Zhang B, Liu H, Shao DD, Liu JB, Wang X, Zhou LN, Hu WH, Ho WZ (2019) IL-22 suppresses HSV-2 replication in human cervical epithelial cells. Cytokine 123:154776. https://doi.org/10.1016/j.cyto.2019.154776
Deretic V, Klionsky DJ (2018) Autophagy and inflammation: a special review issue. Autophagy 14(2):179–180. https://doi.org/10.1080/15548627.2017.1412229
Nighot PK, Hu CA, Ma TY (2015) Autophagy enhances intestinal epithelial tight junction barrier function by targeting claudin-2 protein degradation. J Biol Chem 290(11):7234–7246. https://doi.org/10.1074/jbc.M114.597492
Wu Y, Tang L, Wang B, Sun Q, Zhao P, Li W (2019) The role of autophagy in maintaining intestinal mucosal barrier. J Cell Physiol 234(11):19406–19419. https://doi.org/10.1002/jcp.28722
Hu M, Yang S, Yang L, Cheng Y, and Zhang H (2016) Interleukin-22 alleviated palmitate-induced endoplasmic reticulum stress in INS-1 cells through activation of autophagy. PLoS One 11(1):e0146818. https://doi.org/10.1371/journal.pone.0146818
Das S, St Croix C, Good M, Chen J, Zhao J, Hu S, Ross M, Myerburg MM, Pilewski JM, Williams J, Wenzel SE, Kolls JK, Ray A, Ray P (2020) Interleukin-22 inhibits respiratory syncytial virus production by blocking virus-mediated subversion of cellular autophagy. iScience 23(7):101256. https://doi.org/10.1016/j.isci.2020.101256
Acknowledgements
We thank the cooperation of all participates. This study was supported by grants from the Guangxi Natural Science Foundation Program (2020GXNSFBA159062).
Funding
Funding was supported by Natural Science Foundation of Guangxi Province (Grant Nos. 2020GXNSFBA159062).
Author information
Authors and Affiliations
Contributions
HN and HY performed the main experiments and wrote the manuscript. YL and WY analyzed the raw data. ZL, YL and SC revised the article. YC and TZ designed and conducted the whole work. All authors read and approved the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors have no conflict of interests to declare regarding the publication of this paper.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Nong, H., Yuan, H., Lin, Y. et al. IL-22 promotes occludin expression by activating autophagy and treats ulcerative colitis. Mol Cell Biochem (2023). https://doi.org/10.1007/s11010-023-04806-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11010-023-04806-z